Ozempic and kidney disease: Does it damage kidneys or protect them?
The “weight loss drug” Ozempic is now a proven "renal shield" that can slash your risk of kidney failure by up to 24%.
Key highlights
- Ozempic (semaglutide) is an FDA-approved GLP-1 medication for type 2 diabetes management, cardiovascular risk reduction, and reducing the risk of worsening kidney disease in patients with chronic kidney disease and type 2 diabetes.
- In the FLOW trial, semaglutide reduced the risk of kidney diseases, including kidney failure or death, by 24% compared to placebo.
- Ozempic can temporarily affect kidney function and cause acute kidney injury when patients experience severe dehydration due to vomiting or diarrhea.
- Patients with moderate CKD (stage 3) can usually take Ozempic safely, while those with severe CKD or on dialysis require careful monitoring.
- Healthcare providers may prescribe a combination of Ozempic and SGLT2 inhibitors like Farxiga or Jardiance to maximize kidney protection.
If you have type 2 diabetes, you might have heard of Ozempic, which is a popular medication used to treat type 2 diabetes in adults and manage body weight (off-label). If you have diabetes along with chronic kidney disease, you might wonder: Is this popular drug good for your kidneys or not? If you search on Google, you may see conflicting answers. Some articles might scare you with stories that link Ozempic to kidney failure, while your doctor may recommend the same medication to help protect your kidneys. So what is the truth?
On January 28, 2025, the U.S. Food and Drug Administration (FDA) approved Ozempic to reduce the risk of worsening kidney disease and cardiovascular death in adults. This approval was an important milestone in kidney disease treatment, offering a new option to reduce the risk of complications, such as heart disease, dialysis, or a kidney transplant.
Ozempic can increase the risk of kidney problems in certain conditions when you have severe dehydration due to vomiting and diarrhea. Severe dehydration leads to acute kidney injury. In contrast, Ozempic protects kidney function and prevents kidney failure in patients with chronic kidney disease. Clinical trials show that semaglutide, which is the active ingredient of Ozempic, can slow the progression of chronic kidney disease in people with type 2 diabetes mellitus. The medication is not only used for lowering blood sugar levels and treating obesity but also as a primary tool for kidney-saving care.
In this article, we’ll explain how Ozempic works, what current research says about its effects on kidney health, who should avoid using it, and the key precautions patients should know.
Why your kidneys are at risk with diabetes
Your kidneys are made up of millions of tiny filtering units called nephrons, which help remove waste and excess fluid from your blood. In type 2 diabetes, high blood sugar levels put extra strain on these filters, which can damage the nephrons and reduce overall kidney function.
Kidneys are the natural filters for your body. They remove waste, extra fluids, and toxins from your blood while keeping essential nutrients. Doctors measure kidney function using eGFR (estimated Glomerular Filtration Rate), which estimates how much blood your kidneys can filter each minute. A higher eGFR indicates healthy kidney function, while a lower eGFR means your kidneys are not filtering properly.
When you have high blood sugar for a long time, it can damage the tiny blood vessels in your kidneys, a condition called diabetic nephropathy. These vessels become “leaky,” allowing protein (albumin) to escape into your urine, a sign called albuminuria. Over time, the damage leads to scarring (fibrosis) in the kidneys, which reduces their ability to filter blood and causes a decline in GFR.
Nearly 40% of Americans with type 2 diabetes develop chronic kidney disease at some point in their lives, often without noticing symptoms until later stages.
Kidney disease doesn’t just affect the kidneys. It also increases the risk of heart diseases such as heart attack and stroke. Therefore, the main goal of treatment is not just to manage blood sugar levels but also to preserve kidney function, slow disease progression, and protect overall heart and vascular health.
How does Ozempic help the kidneys?
Ozempic is a GLP-1 Ra (glucagon-like peptide-1 receptor agonist) approved by the FDA for use in people with type 2 diabetes and chronic kidney disease. It mimics the activity of the natural GLP-1 hormone. The medication works in the following ways in your body.
- It suppresses appetite to lower blood sugar levels and support weight management
- Ozempic delays digestion by slowing gastric emptying to manage blood sugar spikes after eating
- The medication increases insulin release from beta cells of the pancreas when blood glucose levels are high
Ozempic not only promotes weight loss but also helps protect heart and kidney health. Clinical studies show it can reduce the risk of major cardiovascular events such as heart attacks and strokes, and slow kidney damage in people with type 2 diabetes.
eGFR acts as a speedometer of the kidney. A declining eGFR shows that the kidneys are not functioning optimally. Studies demonstrate that Ozempic can slow this decline and improve kidney functionality.
Ozempic also reduces inflammation directly in kidney tissues and protects the delicate nephrons from damage. The medication is used to treat Cardiovascular-Kidney-Metabolic (CKM) Syndrome. This means Ozempic lowers blood sugar levels, helps with weight loss and also protects against kidney damage.
Ozempic benefits the kidneys in the following ways:
Reducing the “leak” (Albuminuria)
Ozempic helps reduce pressure inside the filtering units of the kidneys (glomeruli). This directly lowers the amount of protein leaks into urine, an early marker of kidney damage. This effect helps protect the kidneys and slow the progression of chronic kidney disease in people with type 2 diabetes.
Slowing the decline (eGFR)
Ozempic helps protect your kidneys by controlling blood sugar, managing blood pressure, and reducing inflammation. These effects slow the decline in eGFR and improve kidney functionality over time.
The cardiovascular connection
Ozempic protects the kidneys by protecting cardiac and vascular health. The medication reduces the risk of cardiovascular diseases such as stroke, myocardial infarction, hypertension, and heart failure, and ensures the kidneys get a steady and healthy blood supply.
What the research says: The FLOW trial and SUSTAIN-6
Clinical trials have demonstrated that semaglutide protects kidney health. FLOW and SUSTAIN‑6 trials show that semaglutide slows the progression of chronic kidney disease, reduces the risk of kidney failure, and lowers the incidence of worsening kidney function in patients with type 2 diabetes.
The FLOW trial
The FLOW trial was a double-blind, placebo-controlled clinical trial designed to test whether semaglutide (the active ingredient in Ozempic) could protect kidney function in people with type 2 diabetes and chronic kidney disease. This study enrolled 3,533 participants who received either semaglutide (1 mg) or a placebo along with standard care.
Patients taking semaglutide experienced a 24% decrease in risk of major kidney disease events, including kidney failure, a large decline in kidney function, the need for dialysis or transplant, or death related to kidney or cardiovascular causes.
SUSTAIN-6 insights
According to the SUSTAIN-6 clinical trial, people with type 2 diabetes, chronic kidney disease, and high cardiovascular risk were grouped by their kidney risk using KDIGO categories (low, moderate, high, very high). They were treated with once-weekly semaglutide or placebo, and kidney outcomes were observed over 2 years.
Participants taking semaglutide showed a significant reduction in kidney disease progression across all KDIGO risk groups as compared to placebo. This shows that semaglutide can protect the kidneys and even improve kidney risk status in people with diabetes.
The SELECT trial
In the SELECT trial, people with overweight or obesity and heart disease, but without diabetes, were given once-weekly semaglutide 2.4 mg. The study found that semaglutide helped protect the kidneys. Only 1.8% of patients on semaglutide had serious kidney problems like kidney failure or a drop in kidney function, as compared to 2.2% on placebo. After 2 years, semaglutide slowed the decline in kidney function, especially in people who already had lower kidney function at the start. This shows that semaglutide can help keep kidneys healthier in people with overweight or obesity, even if they don’t have diabetes.
Does Ozempic damage the kidneys?
Many people worry about whether Ozempic can harm the kidneys. In most cases, Ozempic benefits the kidneys by slowing the progression of kidney disease and reducing the decline in eGFR.
However, there are certain conditions when Ozempic may temporarily affect kidney health. These include the following:
- Ozempic can cause gastrointestinal side effects such as nausea, vomiting, diarrhea, and stomach pain. For most people, these side effects fade over time.
- In some cases, persistent nausea, vomiting, or diarrhea can lead to severe dehydration.
- Severe dehydration lowers blood volume and blood pressure, which reduces blood flow to the kidneys.
- This can cause acute kidney injury (AKI). AKI is a reversible condition if you address it promptly, but it can be serious if left untreated.
If you have stomach flu, skip your Ozempic dose to help prevent AKI (acute kidney injury) and discuss it with your healthcare provider.
Ozempic carries a black box warning. The medication is contraindicated for people with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN 2). Other risks include gallbladder issues and pancreatitis, but these are less common and are not related to kidney health.
Who is eligible for Ozempic for kidney protection?
The FDA has approved Ozempic for adults with type 2 diabetes who also have chronic kidney disease (CKD). This means people who have diabetes, along with signs of kidney damage such as a reduced eGFR or protein in the urine, can use Ozempic for kidney protection.
Consult with your healthcare provider before using Ozempic if you have chronic kidney disease (CKD). Patients with moderate CKD (eGFR 30–59) can usually take Ozempic safely, but those with severe CKD (eGFR below 30) should consult their doctor first, since there is limited research in this group.
According to a SELECT clinical trial, adults who were overweight or obese and had CKD without diabetes received 2.4 mg of semaglutide weekly for 104 weeks. Semaglutide reduced the risk of major kidney events such as kidney-related death, kidney transplant, a 50% drop in eGFR, or onset of microalbuminuria. These findings suggest that semaglutide protects kidney function even in people without diabetes. However, semaglutide use for kidney protection in people without diabetes is off-label and not FDA-approved.
Can you take Ozempic with stage 3, 4, or 5 kidney disease?
The use of Ozempic depends on your kidney health. Your doctor measures kidney health through eGFR and the stages of chronic kidney disease (CKD). Treatment of chronic kidney disease with Ozempic needs continuous monitoring.
Dosage based on eGFR
If you have kidney disease, your doctor will get your eGFR (estimated glomerular filtration rate) checked before starting treatment and adjust the Ozempic dosage accordingly.
The general guidance based on eGFR is as follows:
- Normal to mild CKD (eGFR 60+): In this stage, the kidney function is normal or only mildly reduced, and no dose adjustment is required. Patients can take the standard dose and receive the full benefits for blood sugar control and kidney protection.
- Moderate CKD (Stage 3 / eGFR 30-59): Ozempic can typically be prescribed in patients with stage 3 CKD. The kidney benefits usually outweigh the risks. Doctors will monitor kidney function and watch for dehydration, especially if gastrointestinal side effects occur.
- Severe CKD (Stage 4 / eGFR 15-29): Ozempic may still be used in patients with stage 4 CKD, but it should be administered under the guidance of a nephrologist. They will carefully titrate the dose and monitor the patient closely to ensure safety, manage kidney function, and minimize the risk of potential side effects of semaglutide.
- Kidney failure (Stage 5 / dialysis): Ozempic is generally not recommended for routine use in patients on dialysis due to limited research on its safety and efficacy in this group. However, it can be used under the strict medical supervision of a Nephrologist to ensure safety and avoid side effects.
Important precautions
If you are on dialysis, your fluid balance should be carefully controlled. Side effects of Ozempic, such as nausea, vomiting, or diarrhea, can make hydration difficult to manage. Therefore, always consult with your doctor before using GLP-1 medications.
Managing side effects for kidney patients
Ozempic can cause side effects such as nausea, vomiting, and diarrhea that can affect your kidneys. Nausea or vomiting from Ozempic,” often called ‘Ozempic stomach,” can be risky for patients with kidney issues because dehydration can worsen kidney function and make existing kidney problems more severe. You can manage dehydration in the following way:
- Drink plenty of fluid regularly, even if you are not feeling thirsty. It will keep you hydrated.
- Take electrolyte drinks to replace electrolytes lost during vomiting and diarrhea.
- Try to eat small, frequent meals to help reduce nausea.
Consult with your nephrologist if you experience the following warning signs:
- Decrease in urination or a change in urine output
- Unexplained fatigue or tiredness
- Persistent vomiting or diarrhea
Comparing Ozempic to other options for kidney health
Ozempic is very helpful in lowering the progression of kidney disease in patients with or without diabetes. The comparison of Ozempic to other treatment options is as follows:
Ozempic vs. Trulicity vs. Mounjaro
Most GLP-1 medications have shown kidney benefits, but semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound) have the strongest clinical evidence for slowing kidney disease progression.
SGLT2 Inhibitors (Farxiga, Jardiance)
SGLT2 inhibitors such as Farxiga and Jardiance protect the kidneys by blocking a transporter in the kidneys that normally reabsorbs glucose and sodium. This causes more glucose and sodium to leave the body in urine, which lowers pressure in the kidney’s filtering units (glomeruli) and reduces fluid overload and blood pressure. These effects help preserve kidney function and slow the progression of chronic kidney disease.
Healthcare providers prescribe the combination of GLP-1 and SGLT2 inhibitors for maximum kidney protection if patients can tolerate it.
| Ozempic (semaglutide; GLP‑1 RA) | SGLT2 Inhibitors | |
|---|---|---|
| Mechanism of action | It is a GLP‑1 receptor agonist that increases insulin secretion, decreases glucagon, slows gastric emptying, reduces appetite | It blocks sodium‑glucose co‑transporter‑2 in kidney and excrete more glucose in urine |
| Blood sugar (HbA1c) | It has strong glucose lowering effect (lowers HbA1c by 1.0–2.1%) | The medication also reduce HbA1c (by 0.7–1%) |
| Weight loss | Significant weight reduction (often 5–15% or more) | Mild to moderate weight loss (2–4 kg) |
| Cardiovascular (MACE) | Reduces risk of major adverse cardiovascular events and improves kidney outcomes | Reduce risk of major cardiovascualr events and improve kidney outcomes |
| Kidney protection | Reduces albuminuria and slows kidney decline in patients with prexisting renal disease | Strong reduction in kidney disease progression and composite renal outcomes |
| Route of administration | Subcutaneous injection (weekly) | Oral tablet (daily) |
| Common side effects | GI symptoms (nausea, vomiting, diarrhea, and constipation) and injection site reactions | Genital infections, urinary tract infectiobs (UTIs) and dehydration |
5 signs of kidney trouble to watch for while on Ozempic
It is important to monitor the side effects while taking Ozempic. Watch for these signs that could indicate your kidneys need extra care:
- Swelling (edema): If you have swelling on your ankles, feet, or hands, it could be a warning sign of kidney disease.
- Changes in urination: If you notice any changes in your urination, such as urinating much more or much less frequently than usual, or if your urine appears foamy, this could indicate protein leaking into your urine, which may be a sign of kidney damage.
- Unexplained fatigue: If you feel unusually tired or weak, it may indicate that waste is building up in your blood.
- Shortness of breath: If you feel out of breath even with little activity, it might be due to fluid buildup in the body.
- Persistent nausea: Persistent nausea that lasts beyond the first few weeks could indicate waste buildup or severe dehydration.
If you experience severe vomiting or diarrhea and cannot drink fluids, stop taking Ozempic and contact your healthcare provider immediately to prevent kidney damage.
Practical tips for protecting your kidneys while on Ozempic
Ozempic is not directly linked to kidney damage. However, side effects of the medication, such as nausea, diarrhea, and vomiting, can cause kidney damage. You can protect your kidneys by following these steps:
- Hydration: Hydration is very important to keep your kidneys functioning. Therefore, drink water consistently and don’t wait until you are thirsty.
- Monitor blood sugar: It is important to monitor your blood glucose level regularly to avoid fluctuations in blood sugar levels, as it can affect your kidney function.
- Regular lab work: Regular follow-ups with your healthcare provider at least once or twice a year, along with your lab reports, are necessary so your healthcare provider can check your eGFR and urine albumin at least once or twice a year.
- Communicate: Always inform your healthcare provider if you start a new medication, especially NSAIDs like ibuprofen, or if you become ill. These factors can affect kidney function and may require adjustments to your treatment.
Cost and insurance coverage
Ozempic is FDA-approved for adults with type 2 diabetes and for reducing the risk of kidney disease progression, kidney failure, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease (CKD). Wegovy is FDA-approved for treating obesity and managing cardiovascular risks such as hypertension, myocardial infarction, and heart attack. The medication is not currently approved for protecting kidney function in non-diabetic adults with CKD.
If you were prescribed Ozempic for an FDA-approved indication, your insurance provider will typically cover the drug.
If you have commercial drug coverage for Ozempic, you could pay as low as $25 for up to a 3-month prescription if eligible for the Ozempic Savings Card. If you are uninsured or your insurance plan doesn’t cover Ozempic, you could pay $349-499 per month through NovoCare Pharmacy.
Novo Nordisk offers a patient assistance program (PAP) for Ozempic for patients who meet the eligibility criteria, including the insurance and income requirements. There is no registration fee or monthly charges.
FAQs
Does Ozempic damage kidneys or protect them?
Ozempic typically protects the kidney functions. However, acute kidney injury (AKI) usually occurs due to its side effects (dehydration, vomiting, or diarrhea), not due to the drug itself. Long-term studies show semaglutide can slow the progression of chronic kidney disease in people with type 2 diabetes.
Can you take Ozempic if you have stage 3 kidney disease?
Yes, at your healthcare provider’s discretion, you can take Ozempic if you have stage 3 kidney disease, because this medication is FDA-approved to reduce the risk of worsening kidney disease, cardiovascular death, and the progression of chronic kidney disease (CKD). Consult your healthcare provider before starting the medication to ensure safety and effectiveness.
What is the best GLP-1 for kidney disease?
The best GLP-1 medication for the protection of kidney disease is semaglutide (Ozempic), based on the clinical trials. Other GLP-1s like dulaglutide (Trulicity) and liraglutide (Victoza) also help reduce protein urea and improve kidney function, but semaglutide has the strongest evidence.
Can I take Ozempic if I’m on dialysis?
Ozempic is usually not indicated in patients on dialysis. If you are on dialysis and considering Ozempic, consult with your healthcare provider first. They will determine whether it is suitable for you.
Does Ozempic need to be adjusted for kidney function?
Ozempic does not require a dose adjustment even if you have stage 3 kidney disease. However, your doctors may monitor kidney function, hydration, and side effects closely, especially if gastrointestinal issues like vomiting or diarrhea occur, because these can temporarily affect the kidneys.
Can Ozempic cause dehydration and kidney failure?
Ozempic itself does not directly cause kidney failure, but it can contribute to dehydration due to its side effects, such as vomiting and diarrhea. If the body loses too much fluid due to vomiting or diarrhea, it can lead to acute kidney injury.
What are the signs of kidney problems on Ozempic?
Signs of kidney problems while taking Ozempic are related to dehydration or reduced kidney function. These may include:
- Decreased urine output or dark-colored urine
- Swelling in the legs, ankles, or around the eyes
- Fatigue or weakness
- Nausea, vomiting, or persistent diarrhea (which can worsen dehydration)
- Shortness of breath or confusion in severe cases
If any of these appear, consult your doctor immediately.
How does it compare to Jardiance or Farxiga (SGLT2 inhibitors)?
Ozempic (a GLP-1 receptor agonist) and Jardiance/Farxiga (SGLT2 inhibitors) both help protect kidneys in people with type 2 diabetes, but they work differently:
- Ozempic (GLP-1) helps reduce blood sugar, promotes weight loss, lowers inflammation, and slows kidney disease progression.
- SGLT2 inhibitors (Jardiance, Farxiga) help the kidneys by reducing glucose and sodium reabsorption in the kidneys, lowering blood pressure, and reducing protein leakage in urine.
As the mechanisms of both medications are different, doctors may now prescribe them in combination for dual protection.
Will I still lose weight on the 1.0 mg kidney dose?
Yes, most people still experience weight loss on the 1.0 mg dose of Ozempic used for kidney protection. However, this dose is lower than the dose used for weight management, but it still reduces appetite and promotes weight loss.
Conclusion: Protecting your kidneys with Ozempic
Ozempic does not directly affect your kidneys. It can harm the kidneys indirectly if dehydration occurs due to vomiting or diarrhea. However, the medication is FDA-approved to protect kidney function long-term for people with diabetes and chronic kidney disease. The medication not only lowers blood glucose levels in your body, but also benefits your heart, kidneys, and weight.
The decision to use Ozempic with kidney disease is personal and should be made in coordination with your healthcare provider. Do not let fear prevent you from exploring a treatment that could help preserve kidney health. Discuss the FLOW trial results with your nephrologist or endocrinologist at your next appointment to understand how Ozempic might fit into your care plan.
